Top Markets
#1 Black Phoenix Black Phoenix +367.56%
#2 Islamic Coin Islamic Coin +158.20%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.03%
#5 Akedo Akedo +41.87%
#6 Acurast Acurast +35.56%
#7 BasedHype BasedHype +29.98%
#8 GoPlus Security GoPlus Security +22.00%
#9 Cryptopia Cryptopia +21.42%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +21.15%
Coin of the day
Black Phoenix Black Phoenix
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Destiny Pharma plc Destiny Pharma plc

Destiny Pharma plc

DEST
Hisse Senetlerindeki Sıralama #41146
Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in... Destiny Pharma plc is a biotechnology company based in Brighton, UK, founded in 1996, specializing in the identification, progression, and market introduction of pharmaceutical solutions for infectious diseases. The company's clinical pipeline includes NTCD-M3, currently in Phase III trials to prevent recurring Clostridioides difficile infections. Its XF-73 program features XF-73 Nasal, undergoing Phase II development for the prevention of post-surgical staphylococcal infections, and XF-73 Dermal, which is in Phase I for treating bacterial skin infections resistant to antibiotics. Additionally, Destiny Pharma's preclinical efforts involve SPOR-COV, a biotherapeutic product aimed at preventing COVID-19 and other viral respiratory diseases, and XF Drugs Biofilm, targeting antibiotic-resistant biofilm and bacterial aggregate infections. The company is also investigating further applications of its XF drugs for respiratory, oral mucosa, and ocular infections. Destiny Pharma maintains strategic alliances with various organizations, including China Medical System Holdings Limited, SporeGen Limited, the University of Southampton, Aston University, the University of Sheffield, Cardiff University, and Tianjin Medical University.
Hisse Fiyatı
$0.04082105
Son senkronizasyon: 2024-08-12
Piyasa Değeri
$39.09K
Değişim (1 gün)
-19.83%
Değişim (1 yıl)
0.00%
Ülke
GB
Ticaret Destiny Pharma plc (DEST)

Kategori

Healthcare
Destiny Pharma plc (DEST) için gelir
Dec 2023 itibarıyla gelir TTM: $1.06M
Destiny Pharma plc şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) $1.06M'dir. 2022 yılında şirketin geliri $186.91K önceki yıla göre artış 2021 yılındaki $182.56K gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Destiny Pharma plc için 2013 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
2026 (TTM) $1.06M 0.00%
2023 $1.06M 466.34%
2022 $186.91K 2.39%
2021 $182.56K 972.50%
2020 $17.02K -95.80%
2019 $405.66K 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 1,192,485.48%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 568,715.68%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B 955,040.28%
BE